Engineered IL-18 variants with half-life extension and improved stability for cancer immunotherapy.
经基因工程改造的IL-18变体,具有延长半衰期和提高稳定性,可用于癌症免疫治疗
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-011789
Bainbridge Travis W, Wang Lifen, Moskalenko Marina, Herrera Robert, Paluch Maciej T, Sun Dawei, Tasneem Kazi, Saini Harpinder, Sadek Manal, Kwong Mandy, Kim Yoon Min, Bhatt Jay M, Tam Christine, Chan Pamela Pui Fung, Ovacik Ayse Meric, Masureel Matthieu, Zhao Yue, Sockolosky Jonathan T, Qu Yan, West Nathaniel R, Bulutoglu Beyza